PSEUDOMONAS AERUGINOSA INFECTION
Clinical trials for PSEUDOMONAS AERUGINOSA INFECTION explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA INFECTION trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibiotic combo targets Drug-Resistant pneumonia
Disease control Not yet recruitingThis early-stage study tests a new drug called MP101, given alongside standard antibiotics, for adults with a severe lung infection caused by Pseudomonas aeruginosa bacteria. The main goal is to check if MP101 is safe and tolerable in 18 participants. Researchers will also measur…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
Personalized antibiotic dosing could save ICU patients
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Standard dosing often leads to levels that are too low or too high. Researchers will test a personalized dosing plan based on each patient's kidney func…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC